News

Anturol Gel, an oxybutynin gel incorporating Antares’ advanced transdermal delivery (ATD) Gel technology, is indicated for treatment in patients with overactive bladder (OAB). FDA is expected to complete

ViroXis has started a Phase II trial evaluating a drug substance derived from East Indian Sandalwood oil (EISO). The trial will be a double-blinded, placebo-controlled, dose range-finding trial

Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% is a generic version of Alcon Pharmaceuticals’ Vigamox, an antibiotic solution that is indicated for the treatment of bacterial conjunctivitis. Alcon Pharmaceuticals

Amgen has also agreed to reacquire rights in Brazil to its products that were previously granted to Mantecorp (subsequently acquired by Hypermarcas). Amgen has entered into an agreement

The CVR entitles Sanofi-aventis to receive additional cash payments if specified milestones related to Lemtrada (alemtuzumab MS) are achieved over time or a milestone related to production volumes

The latest TEKLYNX innovation enables auditable tracking of user activity across TEKLYNX’ proven label design, printing, security and tracing applications. In addition to security measures, TEKLYNX CENTRAL CFR

Once the acquisition is completed, SOHM expects to add 17 new product offerings. SOHM president and CEO Shailesh Shah said they not only gain new products to further

The new machine is fully automated and capable of filling and over-encapsulating a wide range of solid and liquid products. At present it has filling stations for powders,

The Divalproex Sodium delayed release tablets USP 125mg, 250mg and 500mg (Valproic Acid Activity) are therapeutically equivalent to Abbott Laboratories’ Depakote delayed-release tablets USP 125mg, 250mg, and 500mg.